The development of glucose-sparing strategies able to provide an efficacious ultrafiltration
profile represents one of the modern goals of peritoneal dialysis therapy. The study
hypothesis is to evaluate the possibility to formulate peritoneal dialysis solutions
containing L-carnitine as an osmotic agent to partially replace glucose.